Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial

NCT03553004 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT03553004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03553004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial
Lead sponsor
University of Kansas Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
January 22, 2019
Completion date
February 1, 2025
Enrollment
18 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer